Treating Comorbid Substance Use and Emotional Disorders

本書強調情緒障礙與物質使用障礙共病的普遍性，以及有效管理這些共存問題的方法。由於物質使用障礙與焦慮障礙共存的可能性是其他情況的兩倍，與情緒障礙共存的可能性則是三倍，因此治療成為一項複雜的挑戰。本書描述了前沿的臨床研究，並結合數據驅動的治療指導方針，提供一種針對這兩個問題的綜合治療方法，以改善臨床結果。本書概述了如何對這些常見共病進行全面整合的治療，能夠更有效地解決障礙並減少症狀，而不僅僅是針對物質使用障礙。這是對臨床醫生和研究人員來說都極具價值的資源。

Kate Wolitzky-Taylor, Ph.D., is a licensed clinical psychologist and Associate Professor in the UCLA Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior. With over 100 publications and continuous NIH funding for her research since her predoctoral training, she has extensive experience in the development, evaluation, and implementation of cognitive and behavioral therapies (CBT) for anxiety disorder and comorbid substance use disorders (SUD). Her research expertise was developed during her doctoral training in the Laboratory for the Study of Anxiety Disorders at the University of Texas at Austin, where she was funded by the National Institute of Mental Health (NIMH) on a National Research Service Award (F31) to examine the efficacy of self-administered treatments for pathological worry. She then completed her clinical internship at the Medical University of South Carolina, where she was funded on a NIMH training grant (T32) focusing on the research and treatment of trauma-related problems. She then completed a 3-year postdoctoral research fellowship in the Anxiety and Depression Research Center at UCLA, in which she was Project Director of a 10-year, multi-site, NIMH-funded longitudinal study examining common and specific risk factors for emotional disorders. She developed expertise in the nature and treatment of comorbid anxiety and SUD through her Early Career Development Award (K23) funded by the National Institute on Drug Abuse (NIDA), in which she developed and evaluated a CBT program for anxiety disorders to be delivered in SUD specialty clinics to those with comorbid anxiety and substance use disorders. Since then, she has received continuous funding for several NIH-funded studies aimed at developing and evaluating novel behavioral treatments for comorbid anxiety disorders and SUD. In addition to her innovative program of work in the treatment of comorbid anxiety and SUD, for which she received the Sobell Innovative Addictions Research Award from the Association for Behavioral and Cognitive Therapies, she is the Center co-Director for a NIMH-funded ALACRITY Center that aims to optimize a digitally-focused, tiered model of care for anxiety and depression among community college students. In addition to her research, she has an extensive history of providing clinical training and supervision to clinical psychology graduate students, postdoctoral fellows, psychiatry residents, and masters' level clinicians in CBT for anxiety disorders, depression, and comorbid emotional disorders and SUD. Dr. Wolitzky-Taylor also treats patients in the UCLA Faculty Practice, specializing in CBT for anxiety, depression, and comorbid emotional disorder/SUD treatment.

Kate Wolitzky-Taylor博士是一位持牌臨床心理學家，並擔任加州大學洛杉磯分校（UCLA）精神醫學與生物行為科學系及塞梅爾神經科學與人類行為研究所的副教授。她擁有超過100篇的出版物，自博士前訓練以來持續獲得國立衛生研究院（NIH）的研究資助，對於焦慮症及合併物質使用障礙（SUD）的認知行為療法（CBT）的開發、評估及實施擁有豐富的經驗。她的研究專長是在德克薩斯大學奧斯汀分校的焦慮症研究實驗室進行博士訓練期間發展的，當時她獲得國立心理健康研究所（NIMH）的國家研究服務獎（F31）資助，研究自我施治對病理性擔憂的療效。隨後，她在南卡羅來納醫科大學完成臨床實習，並獲得NIMH的培訓獎助金（T32），專注於創傷相關問題的研究與治療。之後，她在UCLA的焦慮與抑鬱研究中心完成了為期三年的博士後研究獎學金，擔任一項為期十年、由NIMH資助的多地點縱向研究的專案主任，該研究探討情緒障礙的共同及特定風險因素。她透過國家藥物濫用研究所（NIDA）資助的早期職業發展獎（K23），在合併焦慮症和SUD的性質及治療方面發展了專長，並開發及評估了一個針對焦慮症的CBT計畫，該計畫在SUD專科診所中提供給合併焦慮及物質使用障礙的患者。自那時以來，她持續獲得多項NIH資助的研究經費，旨在開發及評估針對合併焦慮症和SUD的新型行為治療。除了在合併焦慮症和SUD治療方面的創新工作計畫外，她還因該計畫獲得行為與認知療法協會的Sobell創新成癮研究獎，並擔任NIMH資助的ALACRITY中心的共同主任，該中心旨在優化針對社區大學學生的焦慮和抑鬱的數位化分層護理模式。除了她的研究外，她還有豐富的臨床訓練和監督經驗，指導臨床心理學研究生、博士後研究員、精神科住院醫師及碩士級臨床醫師進行焦慮症、抑鬱症及合併情緒障礙和SUD的CBT治療。Wolitzky-Taylor博士也在UCLA教職員診所治療患者，專注於焦慮、抑鬱及合併情緒障礙/SUD的CBT治療。